Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-25-019840
Filing Date
2025-03-03
Accepted
2025-03-03 17:01:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 11874
  Complete submission text file 0001104659-25-019840.txt   13868
Mailing Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037
Business Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037 858-952-5500
CalciMedica, Inc. (Subject) CIK: 0001534133 (see all company filings)

EIN.: 452120079 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91725 | Film No.: 25699198
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 888 SEVENTH AVENUE, 12TH FLOOR NEW YORK NY 10106
Business Address 888 SEVENTH AVENUE, 12TH FLOOR NEW YORK NY 10106 212-651-6380
Aisling Capital V, LP (Filed by) CIK: 0001776233 (see all company filings)

EIN.: 833267456 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A